Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D
NBER Working Paper No. 19948
---- Acknowledgments ----
Funding for this research was provided by the National Institute of Aging, National Institutes of Health (1R01AG042396). The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
---- Disclosure of Financial Relationships for G. Caleb Alexander ----
Dr. Alexander is an ad hoc member of the FDA’s Drug Safety and Risk Management Advisory Committee, serves as a paid consultant to IMS Health, and serves on an IMS Health scientific advisory board. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies.